Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Cantor Fitzgerald
AstraZeneca
Queensland Health
Teva
Merck
Harvard Business School
Cipla
Baxter

Generated: November 14, 2018

DrugPatentWatch Database Preview

Asparaginase - Biologic Drug Details

« Back to Dashboard

Summary for asparaginase

US Patents for asparaginase

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up Georgia State University Research Foundation, Inc. (Atlanta, GA) ➤ Sign Up RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up IBC Pharmaceuticals, Inc. (Morris Plains, NJ) ➤ Sign Up RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up BIOGENERA S.P.A. (Porretta Terme (BO), IT) ➤ Sign Up RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up Immunomedics, Inc. (Morris Plains, NJ) ➤ Sign Up RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up Ecole Polytechnique Federale de Lausanne (EPFL) (Lausanne, CH) ➤ Sign Up RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up Abbott Molecular Inc. (Des Plaines, IL) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for asparaginase

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2007 00027 Denmark ➤ Sign Up PRODUCT NAME: PERFLUTREN-HOLDIGE LIPIDMIKROSAERER
C/GB07/031 United Kingdom ➤ Sign Up PRODUCT NAME: PERFLUTREN-CONTAINING LIPID MICROSPHERES; REGISTERED: UK EU/1/06/361/001 20060920
0267 Netherlands ➤ Sign Up DETAILS ASSIGNMENT: VERANDERING VAN EIGENAAR(S), VERANDERING VAN NAAM VAN DE EIGENAAR(S)
C/GB96/053 United Kingdom ➤ Sign Up PRODUCT NAME: DOXORUBICIN SULPHATE; REGISTERED: UK EU/1/96/011/001 19960621; UK EU/1/96/011/002 19960621
C018/2007 Ireland ➤ Sign Up SPC018/2007: 20071012, EXPIRES: 20190519
C0047 Belgium ➤ Sign Up PRODUCT NAME: DOXORUBICIN HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/96/011/001 19960624
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
US Army
Fish and Richardson
Argus Health
Queensland Health
Medtronic
Moodys
Cerilliant
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.